For a menopause-related search, choose a source category below. These categories also contain products for other uses; they are not a list of suitable treatments.
HORMONES AND SUBSTITUTES
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
CANAGLIFLOZIN: products 1 to 8 of 8.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Canagliflozin 100mg TabDIN 02564556 | General benefit | $0.7228per source unit | Requirements & sourcesBuild cost plan |
| Apo-Canagliflozin 300mg TabDIN 02564564 | General benefit | $0.7515per source unit | Requirements & sourcesBuild cost plan |
| Auro-Canagliflozin 100mg TabDIN 02510367 | General benefit | $0.7228per source unit | Requirements & sourcesBuild cost plan |
| Auro-Canagliflozin 300mg TabDIN 02510375 | General benefit | $0.7515per source unit | Requirements & sourcesBuild cost plan |
| Invokana 100mg TabDIN 02425483 | General benefit | $0.7228per source unit | Requirements & sourcesBuild cost plan |
| Invokana 300mg TabDIN 02425491 | General benefit | $0.7515per source unit | Requirements & sourcesBuild cost plan |
| Jamp Canagliflozin 100mg TabDIN 02543486 | General benefit | $0.7228per source unit | Requirements & sourcesBuild cost plan |
| Jamp Canagliflozin 300mg TabDIN 02543494 | General benefit | $0.7515per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:00 HORMONES AND SUBSTITUTES.
68:04 Corticosteroids.
68:08 Androgens.
68:12 Contraceptives.
68:16 Estrogens.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).
68:24 Parathyroid Agents.
68:28 Pituitary Agents.
68:32 Progestogens and Oral Contraceptives.
68:36 Thyroids.
68:38 Anti-Thyroids.
National Defence, WDH Guide to Menopause, 2026-09-17
Hormone Therapy (HT) previously called Hormone Replacement Therapy replaces estrogen and when needed, progesterone
Ontario Drug Benefit Formulary, Part V, 2026-09-03, p. 38
68:16 Estrogens
68:32 Progestogens and Oral Contraceptives